Annual report pursuant to Section 13 and 15(d)

Fair Value of Other Securities (Details 4)

v3.3.1.900
Fair Value of Other Securities (Details 4) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]                      
Revenues $ 22,478,932 $ 22,140,450 $ 12,681,670 $ 13,987,883 $ 11,896,126 $ 9,345,878 $ 9,019,012 $ 10,047,557 $ 71,288,935 $ 40,308,573 $ 31,286,020
Nonoperating Income (Expense) (3,554,782) (5,022,101) (890,093) (107,066) (3,893,006) (154,275) 1,270,654 472,262 (9,574,042) (2,304,365) 2,662,989
Less: Net Income attributable to non-controlling interest $ (384,221) $ (410,806) $ (412,004) $ (410,175) $ (388,423) $ (389,485) $ (387,135) $ (391,114) (1,617,206) (1,556,157) $ (1,466,767)
Reported Value Measurement [Member] | Unconsolidated Affiliates [Member]                      
Schedule of Equity Method Investments [Line Items]                      
Revenues                 81,789 54,906  
Operating Expenses                 76,755 62,764  
Nonoperating Income (Expense)                 12,469 15,459  
Income from Operations                 17,503 7,601  
Less: Net Income attributable to non-controlling interest                 (8,901) (761)  
Net Income attributable to Partner's Capital                 $ 8,602 $ 6,840